A comparison of 4-hydroxycholesterol:cholesterol and 6-hydroxycortisol:cortisol as markers of CYP3A4 induction

被引：37
|
作者：
Arrhen, Yvonne Marde [1 ]
Nylen, Hanna [2 ]
Lovgren-Sandblom, Anita [2 ]
Kanebratt, Kajsa P. [3 ]
Wide, Katarina [4 ]
Diczfalusy, Ulf [2 ]
机构：
[1] Karolinska Univ Hosp, Huddinge, Sweden
[2] Karolinska Inst, Dept Lab Med, Huddinge, Sweden
[3] AstraZeneca R&D, CVGI IMed DMPK, Molndal, Sweden
[4] Karolinska Inst, Dept CLINTEC, Huddinge, Sweden
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2013年 / 75卷 / 06期
基金：
瑞典研究理事会;
关键词：
CYP3A4; endogenous markers; induction; LC-MS; MS; rifampicin; ENDOGENOUS MARKER; 4-BETA-HYDROXYCHOLESTEROL; HUMANS; 6-BETA-HYDROXYCORTISOL; INHIBITION; RIFAMPICIN;
D O I：
10.1111/bcp.12016
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Aim To compare plasma 4-hydroxycholesterol:cholesterol with urinary 6-hydroxycortisol:cortisol as markers of cytochrome P4503A4 activity before and after treatment with rifampicin for 2 weeks. Method 6-hydroxycortisol and cortisol were determined by liquid chromatography tandem mass spectrometry and 4-hydroxycholesterol was determined by gas chromatographymass spectrometry in three groups of healthy volunteers. Results Induction ratios for 6-hydroxycortisol:cortisol were 1.8, 3.9 and 4.5 for 20mgday1, 100mgday1 or 500mgday1 of rifampicin, respectively. The corresponding ratios for 4-hydroxycholesterol:cholesterol were 1.5, 2.4 and 3.8. Conclusions Plasma 4-hydroxycholesterol:cholesterol gave similar induction ratios to urinary 6-hydroxycortisol:cortisol.
引用
收藏
页码：1536 / 1540
页数：5
相关论文
共 50 条
  • [1] Comparison of Endogenous 4β-Hydroxycholesterol with Midazolam as Markers for CYP3A4 Induction by Rifampicin
    Bjorkhem-Bergman, Linda
    Backstrom, Tobias
    Nylen, Hanna
    Ronquist-Nii, Yuko
    Bredberg, Eva
    Andersson, Tommy B.
    Bertilsson, Leif
    Diczfalusy, Ulf
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (08) : 1488 - 1493
  • [2] Was 4-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?
    Neuhoff, Sibylle
    Tucker, Geoffrey T.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (07) : 1620 - 1621
  • [3] Associations of the CYP3A5*3 and CYP3A4*1G polymorphisms with the pharmacokinetics of oral midazolam and the urinary 6-hydroxycortisol/cortisol ratio as markers of CYP3A activity in healthy male Chinese
    Chan, S. W.
    Xiao, Y.
    Hu, M.
    Yin, O. Q. P.
    Chu, T. T. W.
    Fok, B. S. P.
    Lee, V. H. L.
    Tomlinson, B.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (05) : 552 - 558
  • [4] COMPARISON OF ENDOGENOUS 4BETA-HYDROXYCHOLESTEROL AND 6BETA-HYDROXYCORTISOL WITH CYP3A PROBE DRUGS AS MARKERS FOR CYP3A INDUCTION IN CYNOMOLGUS MONKEY
    Tahara, Harunobu
    Watanabe, Miwa
    Hasegawa, Maki
    DRUG METABOLISM REVIEWS, 2015, 47 : 131 - 131
  • [5] CYP3A4 phenotyping by plasma 4β-hydroxycholesterol?
    Fuhr, U.
    Doroshyenko, O.
    Frank, D.
    Tomalik-Scharte, D.
    Jetter, A.
    Luetjohann, D.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (05) : 372 - 372
  • [6] Kuypers and Vanhove reply to "Was 4-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?' by Neuhoff and Tucker
    Kuypers, Dirk R. J.
    Vanhove, Thomas
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (07) : 1622 - 1623
  • [7] STUDYING OF ACTIVITY OF ISOENZYME CYP3A4 ON CORTISOL/6 B-HYDROXYCORTISOL RATIO IN HUMAN URINE
    Smirnov, V. V.
    Ramenskaya, G., V
    Suchev, D. A.
    Bubolc, A., V
    Savchenko, A. U.
    Paukov, S., V
    Sivkov, A. S.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 107 - 107
  • [8] Gjestad et al. reply to "Was 4-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?' by Neuhoff and Tucker
    Gjestad, Caroline
    Haslemo, Tore
    Andreassen, Ole A.
    Molden, Espen
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (07) : 1624 - 1625
  • [9] Microsomal enzyme induction and clinical aggravation of porphyria:: The evaluation of human urinary 6β-hydroxycortisol/cortisol ratio as the index of hepatic CYP3A4 activity
    Uejima, E
    Takahashi, K
    Morisaki, T
    Takahashi, K
    Ohno, M
    Nishida, Y
    Moriya, M
    Kaido, M
    Abe, K
    Sakoda, S
    Yanagihara, T
    Kurokawa, N
    Azuma, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (12): : 1374 - 1379
  • [10] 4-Hydroxycholesterol level significantly correlates with steady-state serum concentration of the CYP3A4 substrate quetiapine in psychiatric patients
    Gjestad, Caroline
    Haslemo, Tore
    Andreassen, Ole A.
    Molden, Espen
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (11) : 2398 - 2405
12345